EOSedge has been granted regulatory approvals including CE Mark in Europe, Health Canada approval in Canada and TGA approval in Australia
Image: EOSedge offers local and full body, weight-bearing, low-dose biplanar exams. Photo: Courtesy of Business Wire.
French medical imaging and software solutions provider EOS imaging has announced its plans to launch its new generation imaging system – EOSedge, in Europe, Canada and Australia.
EOS said that it intends to showcase the new imaging system at the upcoming Radiological Society of North America (RSNA) 2019 Annual Meeting, in Chicago, Illinois, US.
EOS imaging chief executive officer Mike Lobinsky said: “We engineered EOSedge to equip both radiologists and orthopedic surgeons with a best-in-class imaging system that combines the latest innovations to provide high quality diagnostic capabilities of orthopedic conditions at a low dose.
“Images and data obtained with EOSedge will further fuel our Advanced Orthopedic Solutions, while addressing a broad range of imaging and orthopedic surgery challenges. This breakthrough in orthopedic imaging is the result of a multi-year development effort by our outstanding inter-disciplinary team.”
EOSedge provides unbiased images and precise anatomical data of patients in functional positions
The company’s latest offering EOSedge is set to combine the advanced technological innovations in X-ray detection, low-dose radiation and high image resolution, to offer superior musculoskeletal imaging exams.
In addition, the system is equipped with new Flex Dose technology to modulate the radiation dose, along with high-resolution photon counting detection for optimal image quality of musculoskeletal radiography.
EOS said that its new device has been designed to feature an open cabin that includes a motorized, enlarged patient platform which facilitates easy access to a broader range of patients, and faster patient positioning, in addition to delivering larger fields of examination.
Designed to improve patient comfort and maximise throughput, EOSedge offers local and full body, weight-bearing, low-dose biplanar exams of adult and paediatric patients.
EOSedge, which is under 510(k) review by the US Food and Drug Administration (FDA), has been granted regulatory approvals including CE Mark in Europe, Health Canada approval in Canada and TGA approval in Australia.
Musculoskeletal Radiologist at Imagerie Médicale du Parc and Imagerie Médicale du Créqui Olivier Fantino said: “We have been using the first-generation EOS system since 2011, and this unique orthopedic imaging system has allowed us to develop our practice, serving our referring clinicians with better, more informed exams.
“EOSedge is a leap forward in image quality, both in terms of spatial resolution and image contrast, all with a low radiation dose. Our months of utilization in routine have also proven enhanced patient comfort, facilitated system operation and a strong reduction of exam time. We are thrilled with our experience of EOSedge and expect it to open up new fields of application use in musculoskeletal imaging.”